Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1976 of 5804
-
Time-Restricted eating shows promise for fatty liver disease
Disease control Recruiting nowThis study will assess the impact of time-restricted eating (8 hours of eating each day) with standard of care lifestyle recommendations (hypocaloric, Mediterranean diet and 30 minutes of exercise on at least 5 days/week) on the degree of fat in the liver as measured by magnetic …
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Tiny doses of avastin tested against laser for preemie eye disease
Disease control TerminatedThis randomized clinical trial will compare retinal outcomes with low-dose intravitreous bevacizumab (0.063 mg) versus laser photocoagulation as treatment for infants with type 1 retinopathy of prematurity (ROP). The study also will assess neurodevelopment, refractive error, vis…
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug calms dementia agitation in phase 3 trial
Symptom relief CompletedA study to determine the safety and efficacy of BXCL501 dosing for episodes of agitation associated with dementia when they occur (given as needed \[PRN\]), for a maximum of 28 doses within a 12-week treatment period.
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New MS drug trial for japanese patients shows promise but study stopped early
Disease control TerminatedThe primary objective of this study is to evaluate the efficacy of natalizumab 300 milligrams (mg) subcutaneous (SC) every 4 weeks (Q4W) administrations up to 24 weeks in Japanese participants with relapsing-remitting multiple sclerosis (RRMS). The secondary objectives of the st…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Racial gap in cancer treatment? new study investigates immunotherapy outcomes
Knowledge-focused OngoingThis study compares treatment outcomes between patients of African American/Black (AA) ancestry and European American/White (EA) ancestry currently receiving immune checkpoint inhibitor treatment. Collecting samples of blood and saliva and health and treatment information from ra…
Sponsor: University of Rochester NCORP Research Base • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Week-Long PTSD therapy showdown: can Fast-Track talk beat relaxation?
Symptom relief OngoingThe overall goal of this randomized controlled trial with partial crossover is to compare the effectiveness of 1-week virtual massed Cognitive Processing Therapy (CPT) to 5-day virtual relaxation training (RT) with regard to their ability to reduce posttraumatic stress disorder (…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Virtual reality goggles ease needle pain for kids with cancer
Symptom relief CompletedChildren with cancer almost universally receive port-a-catheters (ports) to deliver medication, fluids, blood products, and conduct blood tests. Port access requires a needle inserted through the skin to the subcutaneous tissue. Despite the application of topical anesthetic, port…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Personalized exercise program shows promise for reducing fatigue in children with cancer
Symptom relief CompletedThe purpose of this multicenter study is to evaluate a personalised and standardised exercise intervention for children and adolescents undergoing anti-cancer treatment.
Phase: NA • Sponsor: Johannes Gutenberg University Mainz • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can training staff save lives? new study targets youth suicide in group homes
Knowledge-focused CompletedThe goal of this 2-arm cluster randomized clinical trial is to test whether an evidence-based staff training and coaching model specifically designed as a response to legal system-involved youths' and frontline staff's mental health needs can improve the safety and suicide outcom…
Phase: NA • Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New pill could ease carcinoid syndrome Flare-Ups
Symptom relief CompletedThe purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome. This study consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New study aims to prevent deadly complications after liver transplant
Disease control Recruiting nowThe aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.
Sponsor: Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could shorter antibiotics work just as well for newborns?
Disease control CompletedA nationwide multicenter open label randomized controlled non-inferiority trial, including 18 departments. The study aims to compare an individualized antibiotic treatment duration with standard seven days of antibiotic treatment for culture negative early-onset infection in term…
Phase: PHASE4 • Sponsor: Ulrikka Nygaard • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New scan could spot hidden thyroid cancer better
Diagnosis Recruiting nowThis phase II study evaluates F-18 tetrafluoroborate (18F-TFB) PET/CT scan in patients with differentiated thyroid cancer. Diagnostic imaging is necessary for planning treatment, monitoring therapy response, and identifying sites of recurrent or metastatic disease in differentiat…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Which surgery is best for frail seniors with broken ankles? new study aims to find out
Disease control Recruiting nowThis will be a multi-centre randomized controlled trial, with London Health Sciences Centre (LHSC) as the lead site. Elderly patients with complex ankle fractures who meet the inclusion criteria and provide consent will be randomized (through a web-based randomization system) to …
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a High-Fat diet help stabilize the brain in mental illness?
Disease control CompletedWide ranging cognitive deficits are major drivers of functional decline and poor outcomes in people with schizophrenia (SZ) and bipolar disorder (BD). Medications do not target pathophysiological mechanisms thought to underlie these deficits. In the search for interventions targe…
Phase: NA • Sponsor: Northern California Institute of Research and Education • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Brain scans reveal what happens when cannabis users with psychosis go cold turkey
Knowledge-focused Recruiting nowCognitive impairment is well established in people with psychosis and is associated with cannabis use. The current study will investigate the neurobiological basis of cognitive change associated with 28-days of cannabis abstinence in people with psychosis and non-psychiatric cont…
Phase: NA • Sponsor: Douglas Mental Health University Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New heart pump trial offers hope for severe heart failure patients
Disease control OngoingThis is a prospective, multi-center, single-arm, early feasibility study that aims to evaluate the safety of the Impella BTR™ in adult patients requiring left-ventricular hemodynamic support, and to evaluate the effectiveness of the Impella BTR™ in supporting patients to recovery…
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Migraine drug AJOVY under Real-World safety spotlight
Symptom relief Recruiting nowTo evaluate the long-term safety of AJOVY in patients under actual use conditions and to specifically evaluate cardiovascular events. In addition, information on efficacy will be collected.
Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New pill for eczema tested in over 1,000 japanese patients
Disease control OngoingThe purpose of this study is to learn about the safety and effectiveness (how well the study treatment works) of the study medicine (CIBINQO) for the potential treatment of atopic dermatitis in people under Japanese medical practice.
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New program aims to protect kids from secondhand smoke in at-risk homes
Disease control Recruiting nowSmoke Free SafeCare (SFSC) is a proposed braided intervention consisting of two evidence-based interventions: Some Things are Better Outside (STBO), aimed at promoting smoke free home rules, and SafeCare, aimed at reducing child maltreatment and improving mother and child outcome…
Phase: NA • Sponsor: Georgia State University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC